AMZN
Amazon.com, Inc.
AMZN has the edge over RUSHB overall, supported by stronger modeled upside and stronger valuation.
RUSHB
Rush Enterprises, Inc.
RUSHB's outlook is improving, though it still trails on the overall score.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
RUSHB Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Under pressure | |
| Strong |
RUSHB's profitability and balance sheet are currently healthy, and its revenue is stable, but its cash flow is under pressure.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over RUSHB in the historical PE scenario, which offers more potential upside but is not a forecast.
RUSHB PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8.7x | $20.11 | -66% |
| Fair | 13x | $30.68 | -49% |
| Expensive | 19x | $45.00 | -24% |
| Current | 20x | $59.58 | — |
| Forward | 21x | $59.58 | — |
Historical ranges are pointers, not guarantees.
RUSHB's PE is 20x, but its earnings don't support one, so it isn't a reliable read right now.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
RUSHB Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
RUSHB has the edge over AMZN on the outlook, with more favorable valuation expectations.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over RUSHB on earnings, with more consistent year-over-year improvement.
RUSHB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.87 | +24% |
| Q3 2026 | $2.31 | +2.7% |
| Q2 2026 | $2.21 | -5.6% |
| Q1 2024 | $2.64 | -13% |
| Q4 2023 | $2.77 | -8.9% |
| Q3 2023 | $2.90 | +3.6% |
| Q2 2023 | $2.97 | +13% |
| Q1 2023 | $3.04 | +38% |
| Q4 2022 | $3.04 | +64% |
RUSHB earned $2.31 per share over the past year, up 2.7% from the year before.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over RUSHB on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over RUSHB on profitability, with a higher operating margin.
RUSHB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.1B | +12% |
| Q2 2026 | $1.9B | -1.6% |
| Q1 2026 | $1.7B | -9% |
| Q4 2025 | $1.8B | -12% |
| Q3 2025 | $1.9B | -0.8% |
| Q2 2025 | $1.9B | -4.8% |
| Q1 2025 | $1.9B | -1.1% |
| Q4 2024 | $2B | -1% |
RUSHB's revenue grew through 2022 and has held roughly level since: $2.1B last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.1% | -0.2 points |
| Q2 2026 | 5.1% | -0.6 points |
| Q1 2026 | 4.9% | -0.1 points |
| Q4 2025 | 5.2% | -0.4 points |
| Q3 2025 | 5.3% | -1 points |
| Q2 2025 | 5.7% | -0.4 points |
| Q1 2025 | 5% | -1 points |
| Q4 2024 | 5.6% | -0.3 points |
RUSHB's operating margin was 5.1% last quarter, about level with the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
RUSHB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$17.8M | -107% |
| Q2 2026 | $51M | -55% |
| Q1 2026 | -$5.6M | -112% |
| Q4 2025 | $31.9M | -88% |
| Q3 2025 | $271.2M | +$291.2M |
| Q2 2025 | $113.8M | -36% |
| Q1 2025 | $45.1M | +$279.3M |
| Q4 2024 | $263.5M | +5330% |
RUSHB has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
RUSHB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +133K shares |
| 1 year | -0.4% | -435K shares |
| 3 years | -4.4% | -5.5M shares |
| 5 years | -7.4% | -9.6M shares |
| Available history | -5% | -6.3M shares |
RUSHB has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $9.2M |
| Q4 2025 | $70.5M |
| Q3 2025 | $7.4M |
| Q2 2025 | $87.4M |
| Q1 2025 | $29.6M |
| Q4 2024 | $5.9M |
| Q3 2024 | $267,000 |
| Q2 2024 | $3.9M |
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
RUSHB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | 0.0x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | 0.1x | Very low |
| Q3 2025 | 0.0x | Very low |
| Q2 2025 | 0.3x | Very low |
| Q1 2025 | 0.3x | Very low |
| Q4 2024 | 0.3x | Very low |
RUSHB has the edge over AMZN on leverage, with a lower net debt burden relative to earnings.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
RUSHB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 72.0 | Overbought |
| Stochastic | 66.6 | Neutral |
RUSHB's weekly RSI is 72 (overbought) and its Stochastic is 67 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
RUSHB PE vs Consumer Cyclical Sector
| Metric | RUSHB | Sector median | Relative |
|---|---|---|---|
| PE | 20x | 18x | 12% above |
| PE % | 87 | 47 | 40 pts above |
RUSHB has the edge over AMZN on valuation relative to its sector.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN is in an uptrend: it's above all five of its weekly moving averages, and 40% above its 200-week average.
RUSHB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $57.4 | 3.9% above |
| 20 week MA | $54.0 | 10% above |
| 50 week MA | $47.4 | 26% above |
| 100 week MA | $42.0 | 42% above |
| 200 week MA | $36.0 | 65% above |
RUSHB is in an uptrend: it's above all five of its weekly moving averages, and 65% above its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has finished higher in five of the last six years, two of them by more than 50%. It's up 15% so far in 2026.
RUSHB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $13.7 | $16.8 | +22% |
| 2021 | $16.8 | $23.2 | +38% |
| 2022 | $23.2 | $25.1 | +8.1% |
| 2023 | $25.1 | $35.3 | +41% |
| 2024 | $35.3 | $36.3 | +2.6% |
| 2025 | $36.3 | $38.3 | +5.7% |
| 2026 YTD | $38.3 | $59.6 | +55% |
RUSHB has the edge over AMZN on returns for 2026, with the stronger performance.